Immunovant Inc. (IMVT)
NASDAQ: IMVT
· Real-Time Price · USD
15.46
-0.34 (-2.15%)
At close: Jun 23, 2025, 3:59 PM
15.60
0.87%
After-hours: Jun 23, 2025, 05:12 PM EDT
-2.15% (1D)
| Bid | 15.18 |
| Market Cap | 2.64B |
| Revenue (ttm) | 160K |
| Net Income (ttm) | -413.84M |
| EPS (ttm) | -2.73 |
| PE Ratio (ttm) | -5.66 |
| Forward PE | -5.55 |
| Analyst | Buy |
| Ask | 17.25 |
| Volume | 880,266 |
| Avg. Volume (20D) | 1,604,932 |
| Open | 15.73 |
| Previous Close | 15.80 |
| Day's Range | 15.32 - 16.08 |
| 52-Week Range | 12.72 - 34.47 |
| Beta | 0.61 |
About IMVT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMVT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMVT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+5.6%
Immunovant shares are trading higher following a Q...
Unlock content with
Pro Subscription
3 months ago
+4.29%
Immunovant shares are trading higher. B of A Securities and Guggenheim reiterated Buy ratings on the stock.
